Immunohistochemistry of the androgen receptor in human benign and malignant prostate tissue.

[1]  P. Walsh,et al.  Immunohistochemical study of androgen receptors in metastatic prostate cancer. Comparison of receptor content and response to hormonal therapy , 1991, Cancer.

[2]  T. H. van der Kwast,et al.  Androgen receptors in endocrine‐therapy‐resistant human prostate cancer , 1991, International journal of cancer.

[3]  F. S. French,et al.  Transcriptional activation and nuclear targeting signals of the human androgen receptor. , 1991, The Journal of biological chemistry.

[4]  W. McGuire,et al.  Variant human breast tumor estrogen receptor with constitutive transcriptional activity. , 1991, Cancer research.

[5]  F. S. French,et al.  Immunohistochemical localization of the androgen receptor in rat and human tissues. , 1990, Endocrinology.

[6]  T. H. van der Kwast,et al.  Androgen receptor heterogeneity in human prostatic carcinomas visualized by immunohistochemistry , 1990, The Journal of pathology.

[7]  F. S. French,et al.  Expression and localization of androgen receptor in the R-3327 Dunning rat prostatic adenocarcinoma. , 1990, Cancer research.

[8]  Chawnshang Chang,et al.  Immunohistochemical study of androgen receptor in benign hyperplastic and cancerous human prostates , 1990, The Prostate.

[9]  C. Chang,et al.  Prostate androgen receptor: immunohistological localization and mRNA characterization. , 1989, Journal of steroid biochemistry.

[10]  F. S. French,et al.  The human androgen receptor: complementary deoxyribonucleic acid cloning, sequence analysis and gene expression in prostate. , 1988, Molecular endocrinology.

[11]  F. S. French,et al.  The rat androgen receptor: primary structure, autoregulation of its messenger ribonucleic acid, and immunocytochemical localization of the receptor protein. , 1988, Molecular endocrinology.

[12]  D. Fentie,et al.  Applicability of nuclear androgen receptor quantification to human prostatic adenocarcinoma. , 1986, The Journal of urology.

[13]  R. Vihko,et al.  Significance of estrogen and progesterone receptors, disease‐free interval, and site of first metastasis on survival of breast cancer patients , 1985, Cancer.

[14]  W. Lakey,et al.  Relationship between concentrations of extractable and matrix-bound nuclear androgen receptor and clinical response to endocrine therapy for prostatic adenocarcinoma. , 1984, The Journal of urology.

[15]  J. Trachtenberg,et al.  Correlation of prostatic nuclear androgen receptor content with duration of response and survival following hormonal therapy in advanced prostatic cancer. , 1982, The Journal of urology.

[16]  G. Williams,et al.  PREDICTING THE RESPONSE OF PROSTATIC CARCINOMA TO ENDOCRINE THERAPY , 1981, The Lancet.

[17]  Desombre Er.  Steroid receptors in breast cancer. , 1984, Monographs in pathology.

[18]  P. Walsh,et al.  Long-term survival after hormonal therapy for stage D prostatic cancer. , 1979, The Journal of urology.

[19]  D. Byar,et al.  Relationship between estrogen receptor values and clinical data in predicting the response to endocrine therapy for patients with advanced breast cancer. , 1979, European journal of cancer.

[20]  P. Walsh.  Physiologic basis for hormonal theapy in carcinoma of the prostate. , 1975, The Urologic clinics of North America.

[21]  N. Bruchovsky,et al.  The effects of testosterone, 5 -dihydrotestosterone and adenosine 3',5'-monophosphate on cell proliferation and differentiation in rat prostate. , 1973, Biochimica et biophysica acta.

[22]  C. Huggins,et al.  Studies on prostatic cancer: I. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate , 1941, CA: a cancer journal for clinicians.